Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 36 | 2023 | 2329 | 5.280 |
Why?
|
Telomerase | 8 | 2023 | 747 | 1.660 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2023 | 2052 | 1.600 |
Why?
|
Adenocarcinoma, Follicular | 4 | 2021 | 325 | 1.070 |
Why?
|
Carcinoma, Papillary | 6 | 2023 | 785 | 0.830 |
Why?
|
Promoter Regions, Genetic | 8 | 2020 | 5789 | 0.710 |
Why?
|
Mutation | 18 | 2023 | 29877 | 0.670 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2866 | 0.630 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 320 | 0.610 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6311 | 0.510 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2021 | 2061 | 0.500 |
Why?
|
Paired Box Transcription Factors | 1 | 2013 | 209 | 0.420 |
Why?
|
Carcinoma | 4 | 2023 | 2334 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2448 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2925 | 0.390 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 350 | 0.380 |
Why?
|
Thyroid Nodule | 3 | 2023 | 760 | 0.370 |
Why?
|
Genetic Predisposition to Disease | 10 | 2016 | 17750 | 0.350 |
Why?
|
Upstream Stimulatory Factors | 1 | 2009 | 18 | 0.340 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2010 | 60 | 0.340 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 319 | 0.330 |
Why?
|
Forkhead Transcription Factors | 3 | 2013 | 1612 | 0.320 |
Why?
|
Genes, ras | 3 | 2017 | 654 | 0.310 |
Why?
|
Paraganglioma | 5 | 2010 | 142 | 0.310 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1135 | 0.300 |
Why?
|
Pheochromocytoma | 4 | 2011 | 328 | 0.300 |
Why?
|
Eukaryotic Initiation Factor-1 | 2 | 2018 | 31 | 0.300 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2712 | 0.280 |
Why?
|
Spain | 6 | 2015 | 486 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2018 | 8491 | 0.210 |
Why?
|
Prognosis | 8 | 2023 | 29561 | 0.210 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1614 | 0.200 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3810 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-ret | 4 | 2013 | 225 | 0.200 |
Why?
|
ras Proteins | 2 | 2018 | 1051 | 0.200 |
Why?
|
Cell Line, Tumor | 10 | 2022 | 16871 | 0.200 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2011 | 734 | 0.190 |
Why?
|
RNA, Messenger | 4 | 2015 | 12774 | 0.180 |
Why?
|
Germ-Line Mutation | 7 | 2021 | 1843 | 0.180 |
Why?
|
Succinate Dehydrogenase | 3 | 2010 | 145 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2016 | 15750 | 0.170 |
Why?
|
ADP-Ribosylation Factors | 1 | 2019 | 133 | 0.160 |
Why?
|
Oncogene Proteins | 1 | 2023 | 721 | 0.160 |
Why?
|
Humans | 50 | 2023 | 759255 | 0.160 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 163 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3615 | 0.160 |
Why?
|
Carcinoma, Medullary | 2 | 2010 | 115 | 0.150 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 82 | 0.150 |
Why?
|
Golgi Apparatus | 1 | 2019 | 404 | 0.150 |
Why?
|
Signal Transduction | 7 | 2023 | 23362 | 0.150 |
Why?
|
Tubulin | 2 | 2012 | 692 | 0.150 |
Why?
|
Mediator Complex | 1 | 2017 | 107 | 0.140 |
Why?
|
Symporters | 1 | 2019 | 361 | 0.140 |
Why?
|
Thyroid Gland | 3 | 2019 | 1169 | 0.140 |
Why?
|
Iodine Radioisotopes | 1 | 2019 | 1030 | 0.130 |
Why?
|
Gene Deletion | 2 | 2015 | 2667 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2020 | 1870 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 894 | 0.120 |
Why?
|
Up-Regulation | 1 | 2023 | 4132 | 0.120 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2015 | 276 | 0.120 |
Why?
|
Neurofibromin 2 | 1 | 2015 | 270 | 0.120 |
Why?
|
Genetic Variation | 1 | 2009 | 6531 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2015 | 375 | 0.110 |
Why?
|
Paclitaxel | 2 | 2012 | 1715 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 752 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1091 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 3 | 2023 | 1111 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 849 | 0.110 |
Why?
|
Mutagenesis | 1 | 2017 | 1233 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9528 | 0.110 |
Why?
|
Cytochrome P-450 CYP3A | 2 | 2010 | 113 | 0.100 |
Why?
|
Models, Genetic | 2 | 2013 | 3443 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1771 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2010 | 307 | 0.100 |
Why?
|
Tumor Burden | 1 | 2017 | 1886 | 0.100 |
Why?
|
Mice | 9 | 2023 | 81138 | 0.100 |
Why?
|
Middle Aged | 21 | 2021 | 219653 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1708 | 0.090 |
Why?
|
Jaw Neoplasms | 1 | 2011 | 70 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1588 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2012 | 346 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1247 | 0.090 |
Why?
|
Gene Silencing | 2 | 2013 | 1512 | 0.090 |
Why?
|
Genomics | 2 | 2023 | 5775 | 0.090 |
Why?
|
Male | 23 | 2022 | 358719 | 0.090 |
Why?
|
Animals | 10 | 2023 | 167838 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2416 | 0.080 |
Why?
|
Genes, Neoplasm | 1 | 2011 | 370 | 0.080 |
Why?
|
Female | 24 | 2021 | 390240 | 0.080 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4111 | 0.080 |
Why?
|
Disease Progression | 2 | 2019 | 13479 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6532 | 0.080 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 161 | 0.080 |
Why?
|
Adult | 19 | 2021 | 219390 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 317 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 253 | 0.080 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2009 | 105 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2022 | 21988 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1902 | 0.080 |
Why?
|
Polymerase Chain Reaction | 4 | 2011 | 6070 | 0.080 |
Why?
|
Gene Dosage | 2 | 2010 | 1218 | 0.070 |
Why?
|
Exons | 2 | 2011 | 2389 | 0.070 |
Why?
|
Iron-Sulfur Proteins | 1 | 2007 | 83 | 0.070 |
Why?
|
Aged, 80 and over | 10 | 2021 | 58867 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 544 | 0.070 |
Why?
|
Loss of Heterozygosity | 3 | 2018 | 659 | 0.070 |
Why?
|
Microtubules | 1 | 2012 | 1072 | 0.070 |
Why?
|
Genotype | 4 | 2020 | 12940 | 0.070 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2010 | 625 | 0.070 |
Why?
|
Neurotoxicity Syndromes | 1 | 2010 | 299 | 0.070 |
Why?
|
Alleles | 3 | 2015 | 6897 | 0.060 |
Why?
|
Young Adult | 10 | 2021 | 58483 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15636 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3797 | 0.060 |
Why?
|
Chromatin | 1 | 2017 | 2939 | 0.060 |
Why?
|
Binding Sites | 2 | 2015 | 6053 | 0.060 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2007 | 243 | 0.060 |
Why?
|
Cell Death | 1 | 2010 | 1669 | 0.060 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 412 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2010 | 4286 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12522 | 0.060 |
Why?
|
Thrombocytopenia | 1 | 2012 | 1174 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1483 | 0.060 |
Why?
|
Base Sequence | 3 | 2011 | 12450 | 0.060 |
Why?
|
Aged | 15 | 2021 | 168617 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2015 | 12580 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 17629 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2007 | 1494 | 0.050 |
Why?
|
Genome, Human | 1 | 2016 | 4412 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3613 | 0.050 |
Why?
|
Risk Assessment | 2 | 2022 | 24049 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18110 | 0.050 |
Why?
|
Haplotypes | 4 | 2010 | 2762 | 0.050 |
Why?
|
Protein Binding | 2 | 2015 | 9334 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9374 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2023 | 80121 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2804 | 0.050 |
Why?
|
Cell Proliferation | 4 | 2019 | 10440 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5793 | 0.050 |
Why?
|
Oncogenes | 2 | 2017 | 1221 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4573 | 0.040 |
Why?
|
Neoplasms | 4 | 2015 | 22019 | 0.040 |
Why?
|
Ultrasonography | 2 | 2023 | 5955 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2021 | 278 | 0.040 |
Why?
|
Prostate | 1 | 2007 | 1781 | 0.040 |
Why?
|
von Hippel-Lindau Disease | 2 | 2010 | 151 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2021 | 383 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 133 | 0.040 |
Why?
|
Founder Effect | 2 | 2009 | 186 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2020 | 7851 | 0.040 |
Why?
|
Adolescent | 10 | 2021 | 87560 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 515 | 0.030 |
Why?
|
Lactic Acid | 1 | 2022 | 1132 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2012 | 1695 | 0.030 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2015 | 11 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3531 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1613 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12106 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2824 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2262 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5635 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20031 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15815 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2015 | 0.030 |
Why?
|
Mitosis | 1 | 2020 | 1195 | 0.030 |
Why?
|
Risk Factors | 2 | 2013 | 74167 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2015 | 347 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1836 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2609 | 0.030 |
Why?
|
Carbanilides | 1 | 2013 | 18 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 671 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3443 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2628 | 0.030 |
Why?
|
Molecular Weight | 1 | 2015 | 2186 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 509 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1208 | 0.030 |
Why?
|
Introns | 1 | 2015 | 976 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1080 | 0.030 |
Why?
|
Benzoxazoles | 1 | 2013 | 89 | 0.030 |
Why?
|
Gene Targeting | 1 | 2015 | 839 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 721 | 0.020 |
Why?
|
Uniparental Disomy | 1 | 2011 | 45 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2015 | 540 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2118 | 0.020 |
Why?
|
Child | 6 | 2021 | 79623 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 1002 | 0.020 |
Why?
|
Isoenzymes | 1 | 2015 | 1690 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 151 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6131 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2015 | 1387 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2012 | 340 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1979 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3584 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4361 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3683 | 0.020 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 241 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9492 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4883 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 40 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1756 | 0.020 |
Why?
|
Adenoma | 2 | 2011 | 2145 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2010 | 160 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 311 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3767 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2039 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3800 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11058 | 0.020 |
Why?
|
Dioxygenases | 1 | 2010 | 342 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2009 | 760 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1619 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2007 | 70 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54204 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8313 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12800 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11123 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2609 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 2755 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 620 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2012 | 0.020 |
Why?
|
Aneuploidy | 1 | 2010 | 551 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4262 | 0.020 |
Why?
|
Penetrance | 1 | 2007 | 388 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2698 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1085 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1953 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2582 | 0.020 |
Why?
|
Glycoproteins | 1 | 2012 | 2203 | 0.020 |
Why?
|
Syndrome | 1 | 2011 | 3276 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1132 | 0.010 |
Why?
|
Child, Preschool | 2 | 2021 | 41935 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11324 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12874 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3449 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2499 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1594 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2007 | 526 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2817 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2011 | 1252 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16532 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4000 | 0.010 |
Why?
|
Age of Onset | 1 | 2009 | 3301 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 2996 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4357 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5214 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 2920 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 1312 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13456 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9466 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41247 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7595 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64879 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21022 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39216 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13621 | 0.010 |
Why?
|